Viewing Study NCT05249556


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:18 PM
Study NCT ID: NCT05249556
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2022-01-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
Sponsor: Immedica Pharma AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module